Immune Dysfunction
11
2
2
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
9%
1 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (11)
Project PHOENIX: Molecular Signatures of Burn Pit Exposure
Natural History of Type 1 Interferonopathies: Insights From a European Cohort
Genotype-phenotype Characterization Study on Genetic Diseases With Immune and Neurological Dysfunctions
Gut Dysbiosis in Spinal Cord Injury Rehabilitation
Electro-acupuncture at Zusanli, Qihai, and Guanyuan Acupoints Regulate Immune Function in Patients With Sepsis
GEOHealth Hub: Household Air Pollution and Cardio-pulmonary and Immune Function Outcomes
Fish Oils and Soybean Lecithin Supplementation Modulate Immune Function in Runners
T Regulatory Cells in Hemodialysis Patients: Observational Study
Pistachios, Performance, Metabolomics
Use of Traditional Chinese Medicine (Ren Shen Yang Rong Tang) Against Microinflammation in Hemodialysis Patients: A Quasi-randomized Controlled Trial
Immune Function in Patients With Obstructive Jaundice